Status:
COMPLETED
Abdominal Binding in Chronic Obstructive Pulmonary Disease
Lead Sponsor:
McGill University
Conditions:
Chronic Obstructive Pulmonary Disease
Dyspnea
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
Conventional approaches to relieve dyspnea (respiratory discomfort) in chronic obstructive pulmonary disease (COPD) have focused on improving respiratory motor drive (e.g., hyperoxia) and/or dynamic r...
Eligibility Criteria
Inclusion
- Male or Female
- Aged ≥40 years
- Ambulatory
- Cigarette smoking history ≥15 pack years
- No change in medication dosage or frequency of administration, with no exacerbations or hospitalization in the preceding 6 weeks.
- Post-bronchodilator Forced Expiratory Volume in 1 second between 30-80% predicted
- Post-bronchodilator Forced Expiratory Volume in 1 second/forced vital capacity ratio of \<70%
Exclusion
- Presence of active cardiopulmonary disease other than COPD
- Use of domiciliary oxygen
- Exercise-induced arterial blood oxyhemoglobin desaturation to \<80% on room air.
- Body Mass Index \<18.5 or ≥35 kg/m2.
- Allergy to latex
- Allergy to lidocaine or its "caine" derivates.
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01852006
Start Date
January 1 2014
End Date
May 1 2015
Last Update
August 26 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montreal Chest Institute; McGill University Health Center & McGill University
Montreal, Quebec, Canada, H2X 2P4